短程、间歇伊马替尼联合传统化疗(NILG09/00方案)在Ph+ ALL治疗中的作用
评价者:杜欣, 文献合成者:凌伟

Outcome of Short Period and Intermittent Imatinib-Phased Chemotherapy(Northern Italy Leukemia Group Protocol 09/00) as Therapy for Ph+ ALL
Reviewer:DU Xin, Literature Co-worker: LING Wei
图1 IM+组与IM-组5年OS、DFS及累计复发率